Stocks Comparison
NewGenIvf vs Progyny: revenue, profit, margins and growth compared
NewGenIvf brought in $23.7M of revenue in fiscal 2025, Progyny $1.3B in fiscal 2025. Revenue changed by +336.3% at NewGenIvf and +10.4% at Progyny on the year before, so NewGenIvf grew faster. NewGenIvf kept 41.7% of its revenue as net profit, Progyny 4.5%. Free cash flow was -$11.1M at NewGenIvf and $191.8M at Progyny.
Side by side, latest fiscal year
| NIVF | PGNY | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $23.7M | $1.3B |
| Revenue growth | +336.3% | +10.4% |
| Net income | $9.9M | $58.5M |
| Net margin | 41.7% | 4.5% |
| Free cash flow | -$11.1M | $191.8M |
| Free cash flow margin | -46.7% | 14.9% |
| Earnings per share (diluted) | $3.04 | $0.65 |
| Cash | $758.6K | $112.2M |
| Debt | n/a | n/a |
| Price to earnings | n/a | 39.1 |
| Market value | $3.3M | $2B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #425 of 646 · Health care | #134 of 646 · Health care |
Over the years
Questions about NewGenIvf and Progyny
Which is bigger by revenue, NewGenIvf or Progyny?
Progyny is bigger by revenue: $1.3B in fiscal 2025, against $23.7M for NewGenIvf in fiscal 2025.
Which keeps more of its revenue as profit, NewGenIvf or Progyny?
NewGenIvf had a net margin of 41.7% in fiscal 2025; Progyny had 4.5% in fiscal 2025.
Which grew revenue faster, NewGenIvf or Progyny?
In their latest fiscal years revenue changed by +336.3% at NewGenIvf and +10.4% at Progyny.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.